Home About Us Research & Development Investors & Media Careers Contact Us

News Highlights

August 12, 2014
Concert Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Company Update; Conference Call Scheduled Today at 8:30 a.m. EDT, Including Discussion of Positive Results from Phase 1 Brain Imaging Trial of CTP-354

August 5, 2014
Concert Pharmaceuticals to Report Second Quarter 2014 Results on August 12, 2014

July 21, 2014
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386



Welcome to Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company. We apply our extensive knowledge of deuterium chemistry to discover and develop novel small molecule drugs.

MedChem News
Deuterium Medicinal Chemistry: A New Approach to Drug Discovery and Development Read more

Issued U.S. Patents

Concert is building a broad patent estate. View List


Concert has presented at a number scientific meetings. View Poster presentations

  ©2009 Concert Pharmaceuticals, Inc.
Design by Digizyme
Home     Sitemap